Searchable abstracts of presentations at key conferences in endocrinology

ea0081p580 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Hypoglycemia and impared hypoglycemia awareness: frequency and relevance in type 1 diabetes under continuous subcutaneous insulin infusion

Mafalda , Carreira Ana , Vieira Ines , Barros Luisa , Melo Miguel , Rodrigues Dircea , Oliveira Patricia , Baptista Carla , Moreno Carolina , Paiva Isabel

Introduction: Continuous subcutaneous insulin infusion (CSII) therapy in type 1 diabetes (T1D) reduces the risk of hypoglycemia. Hypoglycemia remains a treatment-limiting factor. Impared hypoglycemia awareness (IHA) occurs in 25% of T1D cases and seems to be underestimated by continuous glucose monitoring (CGM). Glycemic variability (GV) is a increasingly valued parameter as a predictor of hypoglycemia and risk of chronic complications.Objective: Analysi...

ea0081p590 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Type 1 diabetes on continuous subcutaneous insulin infusion: impact of glycaemic control on quality of life

Carreira Ana , Ferreira Mafalda , Vieira Ines , Lavrador Mariana , Barros Luisa , Baptista Carla , Moreno Carolina , Melo Miguel , Paiva Isabel

Background: In type 1 diabetes (T1D), quality of life (QoL) and the effectiveness of treatment influence each other. QoL has been associated with glycaemic control assessed by HbA1c in T1D on continuous subcutaneous insulin infusion (CSII), but data on the relationship between Continuous Glucose Monitoring (CGM) metrics and QoL are scarce.Objectives: To assess QoL and the association between CGM metrics and QoL in T1D on CSII.Metho...

ea0081p399 | Pituitary and Neuroendocrinology | ECE2022

Familial neurohypophyseal diabetes insipidus: an extremely rare report of a family with a nonsense mutation in the arginine vasopressin gene

Ramalho Diogo , Serra-Caetano Joana , Cardoso Rita , Rosinha Patricia , Filipa Araujo Barbara , Rua Ines , Rodrigues Orlando , Dinis Isabel , Mirante Alice

Introduction: Familial neurohypophyseal diabetes insipidus (FNDI) is a rare form of central diabetes insipidus (CDI) characterized by childhood-onset progressive polydipsia and polyuria due to mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene.Case description: Two male siblings were referred at 1 month of age to exclude CDI owing to a family history of CDI in the father and paternal grandfather. The proband was the fa...

ea0081p666 | Pituitary and Neuroendocrinology | ECE2022

Inferior petrosal sinus sampling in differential diagnosis of adrenocorticotropic hormone (ACTH)-dependent cushing’s syndrome: a tertiary centre experience

Araujo Catia , Martins Ferreira Mafalda , Reis Guiomar Joana , Moreno Carolina , oliveira patricia , Baptista Carla , Gomes Leonor , rodrigues dircea , Paiva Isabel

Introduction: Inferior petrosal sinus sampling (IPSS) has been considered to be the gold standard for differential diagnosis of Cushing’s Disease (CD) and ectopic ACTH secretion (EAS).Aim: To describe the experience of our centre in performing IPSS, its safety and efficacy; assess remission rates from transphenoidal surgery and clinical course; approach to the difficulty in the etiological diagnosis of ACTH-dependent Cushing’s Syndrome.<p c...

ea0081p450 | Reproductive and Developmental Endocrinology | ECE2022

Influence of polycystic ovary syndrome on in vitro fertilization and relationship with the Asn680Ser polymorphism in FSHR gene

Vieira Ines , Filipa Ferreira Ana , Carvalho Alexandra , Dias Conceicao , Fernandes Silvana , Rodrigues Dircea , Cortesao Paulo , Almeida Santos Teresa , Paiva Isabel

Introduction: Polycystic ovary syndrome (PCOS) is a frequent cause of infertility. Its influence on the results of in vitro fertilization (IVF) is controversial, and generally not isolated from the effect of obesity. A relationship between the FSH receptor (FSHR) polymorphism Asn680Ser and the risk and phenotype of PCOS has been studied with conflicting results.Objectives: To analyze the influence of obesity and PCOS on the gonadal axis...

ea0081ep284 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Factors affecting glycemic outcomes using closed-loop systems in real-world

Fabregas Lara Albert , Andujar David Subias , Gregori Ana Romero , Luchtenberg Maria Florencia , Palomares Albert Cano , Mazarico Isabel , Rigla Mercedes

Aims: To evaluate real-world efficacy of closed-loop systems (CLS) (MinimedTM 780G, DBLG1 -Diabeloop- and Control-IQTM Tandem) as well as to assess those predictive factors related with the achievement of near-normal glycemic control.Methods: A prospective, longitudinal, and observational study was performed. It included T1D adults who initiated CLS between April and December 2021 in our hospital and provided data for &gE;3 months (...

ea0081ep1081 | Thyroid | ECE2022

Thyrotoxic crisis presented as psychiatric decompensation

Martins Ferreira Mafalda , Araujo Catia , Lavrador Mariana , Guiomar Joana Reis , Oliveira Patri cia , Moreno Carolina , Paiva Isabel

Introduction: Thyrotoxic crisis is a rare endocrinological emergency with high mortality and it is more frequent in Graves’ disease.Clinical case: A 66-year-old women with schizophrenia was admitted to the Emergency Department due to altered state of consciousness, fatigue, constant moaning interspersed with unusual psychomotor agitation, heteroaggressiveness, diarrhea and anorexia. Lack of compliance with her psychiatric medication, new delusional ...

ea0085oc6.3 | Oral Communications 6 | BSPED2022

Use of 24 weekly decapeptyl SR in central precocious puberty is well-tolerated and efficacious – a two centre study

Lake Lydia , Kothayan Bharathy , Sharratt Isabel , O'Sullivan Jacquelin , Russell Julia , Sharma Veena , Cheetham Tim , Wood Claire , Howard Sasha

Central precocious puberty (CPP) is a common and well-recognised condition characterised by premature activation of the hypothalamic-pituitary-gonadal axis, with consequent potential adverse health and psychosocial outcomes. Standard management of CPP is with periodic injections of gonadotropin-releasing hormone analogue therapy. Decapeptyl SR (Triptorelin pamoate) has for several years been available as a long-acting (12-weekly, 11.25 mg) preparation, but more recently is ava...

ea0090p144 | Pituitary and Neuroendocrinology | ECE2023

Glucocorticoid Resistance Syndrome: a Rare Disorder that we Must not Forget. A Clinical Case

Martin Timon Iciar , Moreno-Ruiz Inmaculada , Meizoso-Pita Olalla , Huguet Isabel , Llavero Valero Maria , Trivino Yannuzzi Vanessa , Sevillano-Collantes Cristina

Primary generalized glucocorticoid resistance or Chrousos syndrome is a rare disorder, which affects all tissues expressing the human glucocorticoid receptor. It has been defined by an absence of overt Cushing’s syndrome (CS) signs (no skin weakness, muscle atrophy, or osteoporosis) associated with biological hypercortisolism consisting of high urinary free cortisol (UFC) and an absence of negative feedback loop of cortisol on HPA, defined as 8-AM cortisol level >50 n...

ea0090p261 | Late-Breaking | ECE2023

Factored aldosterone can help distinguish mineralocorticoid resistance from aldosterone deficit hypoaldosteronism

Gabriel Ruiz Sanchez Jorge , Calle Alfonso , Angel Rubio Herrera Miguel , Paz de Miguel Novoa Maria , Gomez Hoyos Emilia , Runkle Isabel

Introduction: Hypoaldosteronism can be induced by a deficit of aldosterone production (AldDef) or a mineralocorticoid resistance (MinRes). Experts have proposed to use hyperkalemia-based aldosterone values for this purpose. However, there is no a range of aldosterone values indicating one of this type of hypoaldosteronism. In 2008, Adam W. R.1 hypothesized that the factored aldosterone (FAldo) could be useful differentiating hypoaldosteronism secondary to MinRes fro...